Article
Harnessing the potential of epigenetic therapies for childhood acute myeloid leukemia.
Experimental hematology - 1 Jul 2018
Newcombe Ashley A, Gibson Brenda E S, Keeshan Karen
Abstract excerpt
There is a desperate need for new and effective therapeutic approaches to acute myeloid leukemia (AML) in both children and adults. Epigenetic aberrations are common in adult AML, and many novel epigenetic compounds that may improve patient outcomes are in clinical development. Mutations in epigenetic regulators occur less frequently in AML in children than in adults. Investigating the potential benefits of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
